- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 157 results
Speaking Engagement
September 18, 2024
Peter Hsiao to Speak at Think Forward the Future of Food Conference
Conference
September 5, 2024
17th Annual King & Spalding Medical Device Summit
Webinar
August 21, 2024
Managing New and Emerging Data Privacy and Security Risks for U.S. and EU Life Sciences Companies
Conference
May 15, 2024
Annual King & Spalding California Life Sciences Summit
Webinar
March 29, 2024
The Machines Are Coming (And Lawsuits Too): Mitigating Risks of Product Design, Manufacture, and Sale Amidst the AI Revolution
Speaking Engagement
March 15, 2024
Ulf Grundmann to Speak at 27th Marburg Discussions
Speaking Engagement
March 12, 2024
Jeffrey Shapiro and David Farber to Speak at Fogarty Innovation
Webinar
February 15, 2024
The Rise of Government Regulation of Digital Health and Artificial Intelligence/Machine Learning
Speaking Engagement
January 23, 2024
Nikki Reeves to Speak at ACI’s Advanced Legal, Regulatory and Compliance Forum on OTC Drugs
Webinar
January 17, 2024
Year in Review for Drug and Device Advertising and Promotion – Lessons Learned from 2023 FDA Enforcement Letters and Other Key Developments
Webinar
December 11, 2023
#Sponsored: Influencer Marketing 201 for Pharmaceutical and Medical Device Companies
Speaking Engagement
December 7, 2023
Eva Temkin to Speak at Practicing Law Institute